» Articles » PMID: 20582599

Why So Late?!--delay in Treatment of Colorectal Cancer is Socially Determined

Overview
Specialty General Surgery
Date 2010 Jun 29
PMID 20582599
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The interval between symptom onset and therapy in patients with colorectal cancer was studied.

Methods: One hundred twenty three patients with colorectal cancer were included. Demography data, symptoms, consultations, and tumour stage were obtained by standardized questionnaires. Risk factors for delayed treatment were analysed.

Results: Eighty six patients suffered from colonic cancer. The total time between the first symptoms and therapy ranged from 13 to 442 days (mean, 148). Delay of surgical therapy was responsible for significantly higher tumour grades. Delayed start of therapy was found to be correlated to the type of cancer, socioeconomic status, marital status, and quality of first consultation (univariate analysis). On multivariate analyses, type of cancer, marital and socioeconomic status remained significantly associated with delayed treatment (all p values ≤ 0.001, r(2) = 0.50).

Conclusions: The delay in treatment of colorectal cancer depends on socioeconomic status and family background. Achieving equity in colorectal cancer detection may require consideration of high-risk subgroups.

Citing Articles

Inequalities in treatment among patients with colon and rectal cancer: a multistate survival model using data from England national cancer registry 2012-2016.

Ling S, Luque Fernandez M, Quaresma M, Belot A, Rachet B Br J Cancer. 2023; 130(1):88-98.

PMID: 37741899 PMC: 10781675. DOI: 10.1038/s41416-023-02440-6.


Conflicting Guidelines: A Systematic Review on the Proper Interval for Colorectal Cancer Treatment.

Molenaar C, Janssen L, van der Peet D, Winter D, Roumen R, Slooter G World J Surg. 2021; 45(7):2235-2250.

PMID: 33813632 DOI: 10.1007/s00268-021-06075-7.


Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease.

van Zutphen M, Geelen A, Boshuizen H, Winkels R, Geijsen A, Wesselink E Support Care Cancer. 2018; 27(4):1541-1549.

PMID: 30484014 PMC: 6394719. DOI: 10.1007/s00520-018-4560-z.


Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer.

Weber D, Amar L, Godde D, Prinz C Oncotarget. 2018; 9(43):27256-27267.

PMID: 29930763 PMC: 6007480. DOI: 10.18632/oncotarget.25535.


Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.

Bownes L, Stafman L, Maizlin I, Dellinger M, Gow K, Goldin A J Surg Res. 2017; 222:180-186.e3.

PMID: 28988685 PMC: 5742061. DOI: 10.1016/j.jss.2017.09.013.


References
1.
Harris G, Simson J . Causes of late diagnosis in cases of colorectal cancer seen in a district general hospital over a 2-year period. Ann R Coll Surg Engl. 1998; 80(4):246-8. PMC: 2503090. View

2.
Khattak I, Eardley N, Rooney P . Colorectal cancer--a prospective evaluation of symptom duration and GP referral patterns in an inner city teaching hospital. Colorectal Dis. 2006; 8(6):518-21. DOI: 10.1111/j.1463-1318.2006.00967.x. View

3.
Steinert R, Marusch F, Koch A, Ptok H, Reymond M, Gastinger I . [Options for quality improvement in the treatment of rectum carcinoma]. Zentralbl Chir. 2005; 130(5):387-92. DOI: 10.1055/s-2005-836892. View

4.
Graffner H, Olsson S . Patient's and doctor's delay in carcinoma of the colon and rectum. J Surg Oncol. 1986; 31(3):188-90. DOI: 10.1002/jso.2930310311. View

5.
Arbman G, Nilsson E, Sjodahl R . A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg. 1996; 162(11):899-904. View